•
VS
VSTM
Verastem, Inc.
polygonPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
479.03M
Volume
340.34K
52W High
$11.25
52W Low
$4.01
Open
$6.40
Prev Close
$6.36
Day Range
6.33 - 6.69
About Verastem, Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
Latest News
KRAS Inhibitors Market to Witness Explosive Growth at a CAGR of 35% During the Forecast Period (2025–2034) Amid Expanding Therapeutic Landscape | DelveInsight
GlobeNewswire Inc.•Nov 12
High‑Growth Oncology Market Projected For US$900bn in Revenue Despite Policy Headwinds
Benzinga•Jul 23
Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge
Benzinga•Mar 8
Why Enphase Energy Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
Benzinga•Jul 24
Verastem, Inc. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewswire
GlobeNewswire Inc.•Jul 10
Verastem: A Shocking Drop On 'Positive' Data (Maintain Buy)
Seeking Alpha•May 26
Verastem (VSTM) Up on Upbeat Early Pancreatic Cancer Study Data
Zacks Investment Research•May 24
Why Big Lots Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga•Feb 12